New drug combo tested for Tough-to-Treat breast cancer
NCT ID NCT07441486
Summary
This study is testing whether combining two drugs, entinostat and oral paclitaxel, can help control advanced breast cancer that is hormone receptor-positive and HER2-negative. It is for people who have already tried 2-4 other treatments, including specific hormone therapy and chemotherapy. The main goal is to see how long the treatment can keep the cancer from getting worse.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.